Company research / TGTX
TG THERAPEUTICS, INC. (TGTX)
- Sector Manufacturing
- Incorporated DE
- Fiscal year ends Dec 31
For the year ended 2025-12-31, TG THERAPEUTICS, INC. reported revenue of $616.29M. Revenue grew 87.3% from the prior annual period.
Key ratios (year ended 2025-12-31)
20.0%
Operating margin
72.6%
Net margin
69.0%
Return on year-end equity
87.3%
Revenue growth (YoY)
Beyond the statements
Follow the company.
Explore new filings, reported insider transactions and company relationships.